ipriflavone has been researched along with warfarin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Notoya, K; Shirakawa, Y; Taketomi, S; Tsuda, M; Yoshida, K | 1 |
| Anderson, DC; Scoggins, BP | 1 |
| Bencsik, T; Boda, G; Fliszár-Nyúl, E; Kunsági-Máté, S; Lemli, B; Mohos, V; Poór, M | 1 |
3 other study(ies) available for ipriflavone and warfarin
| Article | Year |
|---|---|
Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro.
Topics: Acid Phosphatase; Animals; Bone Development; Bone Marrow; Bone Resorption; Cell Division; Cell Fractionation; Cells, Cultured; Drug Synergism; Femur; Isoflavones; Mice; Organ Culture Techniques; Osteoclasts; Phenotype; Rats; Stem Cells; Stromal Cells; Vitamin K; Warfarin | 1995 |
Potential ipriflavone and warfarin interaction.
Topics: Aged; Anticoagulants; Complementary Therapies; Contraindications; Drug Interactions; Female; Humans; Isoflavones; Osteoporosis; Warfarin | 2007 |
Interactions of casticin, ipriflavone, and resveratrol with serum albumin and their inhibitory effects on CYP2C9 and CYP3A4 enzymes.
Topics: Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Flavonoids; Fluorescence; Humans; Isoflavones; Naproxen; Resveratrol; Serum Albumin; Time Factors; Warfarin | 2018 |